Effect of dexfenfluramine treatment in rats exposed to acute and chronic hypoxia

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 4 PART I, 1998, Pages 1111-1119

  Eddahibi, Saadia ^b   Raffestin, Bernadette ^b   Launay, Jean Marie ^b   Sitbon, Maryvonne ^b   Adnot, Serge ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXFENFLURAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HEMODYNAMICS; HYPOXIA; LUNG BLOOD VESSEL; LUNG PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; RECEPTOR AFFINITY;

EID: 0031956562     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.4.9704095     Document Type: Article

References (23)

1. Brindley, D. N., and J. C. Russell. 1995. Metabolic abnormalities linked to obesity: effects of dexenfluramine in the corpulent rat. Metabolism 44:23-27.
2. Caccia, S., M. Anelli, A. Ferrarese, C. Fracasso, and S. Garattini. 1993. The role of D-norfenfluramine in the indole-depleting effect of D-fenfluramine in the rat. Eur. J. Pharmacol. 233:71-77.
3. Lesch, K. P., B. L. Wolozin, D. L. Murphy, and P. Riederer. 1993. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J. Neurochem. 60:2319-2322.
4. Lee, S. L., and B. L. Fanburg. 1986. Serotonin uptake by bovine pulmonary endothelial cells in culture: I. Characterization. Am. J. Physiol. 250:C761-C765.
5. Bucko, W., G. De Gaetano, and S. Garattini. 1975. Effect of fenfluramine on 5-hydroxytryptamine uptake and release by rat blood platelets. J. Pharmacol 53:563-568.
6. Seiler, K. U., O. Wassermann, and H. Wensky. 1976. On the role of serotonin in the pathogenesis of pulmonary hypertension induced by anorectic drugs: an experimental study in the isolated rat lung. Clin. Exp. Pharmacol. Physiol. 3:323-330.
7. Celada, P., F. Martin, and F. Artigas. 1994. Effects of chronic treatment with dexfenfluramine on serotonin in rat blood, brain, and lung tissue. Life. Sci. 55:1237-1243.
8. Brenot, F., P. Hervé, and P. Petitpretz. 1993. Primary pulmonary hypertension and the appetite suppressant fenfluramine. Br. Heart J. 89: 117-120.
9. Abenhaim, L., Y. Moride, F. Brenot, S. Rich, J. Benichou, X. Kurz, T. Higenbottam, C. Oakley, E. Wouters, M. Aubier, G. Simonneau, and B. Bégaud. 1996. Appetite-suppressant drugs and the risk of pulmonary hypertension. N. Engl. J. Med. 335:609-616.
10. Tschopp, T. B., and M. B. Zucker. 1972. Hereditary defect in platelet function in rats. Blood 40:217-226.
11. Sato, K., S. Webb, A. Tucker, M. Rabinovitch, R. F. O'Brien, I. F. McMurtry, and T. J. Stelzne. 1992. Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat. Am. Rev. Respir. Dis. 145:793-797.
12. Hervé, P., L. Drouet, C. Dosquet, J.-M. Launay, B. Rain, L. Simonneau, J. Caen, and P. Duroux. 1990. Primary pulmonary hypertension in a patient with a familial platelet storage disease: role of serotonin. Am. J. Med. 89:117-120.
13. Eddahibi, S., B. Raffestin, I. Pham, J. M. Launay, P. Aegerter, M. Sitbon, and S. Adnot. 1997. Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats. Am. J. Physiol 272:H1173-H1181.
14. Cheymol, G., J. Weissenburger, J. Poirier, and C. Gellee. 1995. The pharmacokinetics of dexfenfluramine in obese and non-obese subjects. Br. J. Clin. Pharmac. 39:684-687.
15. Adnot, S., B. Raffestin, S. Eddahibi, P. Braquet, and P. E. Chabrier. 1991. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J. Clin. Invest. 87: 155-162.
16. Rowland, N., and J. Carlton. 1988. Dexfenfluramine: effects on food intake in various animal models. Clin. Neuropharmacol. 11 :S33-S50.
17. Matuchansky, C., and J. M. Launay. 1995. Serotonin, catecholamines, and spontaneous midgut carcinoid flush: plasma studies from flushing and nonflushing sites. Gastroenterology 108:743-751.
18. Butt, A. Y., J. Pepke-Zaba, G. Cremona, D. Ravel, and T. Higenbottam. 1995. Effect of dexfenfluramine on isolated human pulmonary arteries (abstract). Am. J. Respir. Crit. Care Med. 151(Suppl.):A735.
19. Weir, E. K., H. L. Reeve, J. M. C. Huang, E. Michelakis, D. P. Nelson, V. Hampl, and S. L. Archer. 1996. Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction. Circulation 94:2216-2220.
20. Naeije, R., P. Wauthy, M. Maggiorini, M. Leeman, and M. Delcroix. 1995. Effects of dexfenfluramine on hypoxic pulmonary vasoconstriction and embolic pulmonary hypertension in dogs. Am. J. Respir. Crit. Care Med. 151:692-697.
21. Laude, E. A., C. J. Emery, and G. R. Barer. 1997. Chronic fenfluramine and the pulmonary pressor response to serotonin in the rat (abstract). Am. J. Respir. Crit. Care Med. 155:A634.
22. Pitt, B. R., W. Weng, and A. R. Steve. 1994. Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture. Am. J. Physiol 266:L178-L186.
23. Seuwen, K., and J. Pouyssegur. 1990. Serotonin as a growth factor. Biochem. Pharmacol. 39:985-990.